16 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Update of the 2013 ... Task Force on Clinical ... ACCAHA2017 #cardiology #treatment ... #algorithm #sCHF
Intestinal Manifestations of HIV, IBD in HIV - IBD Algorithm

HIV + IBD Background
HIV + IBD Treatment
Intestinal
IBD in HIV - IBD Algorithm ... Background HIV + IBD Treatment ... Intestinal TB (ITB) GI ... Intestinal #HIV #IBD #Algorithm ... gastroenterology #IBDAlgorithm
Malignant Hyperthermia is a very rare, but life-threatening condition that can occur after using certain anesthetic
diagnosis #management #treatment ... #algorithm ... (2018). ... Diagnosis and treatment ... Therapeutics and Clinical
Treatment of Stable Wide-Complex Tachycardia
Regular
 • If ventricular tachycardia or uncertain rhythm:
    -
Treatment of Stable ... irregular protocol #Stable ... #WideComplex #Tachycardia ... #Treatment #management ... #cardiology #algorithm
IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis
Algorithm for the management of acute bacterial rhinosinusitis.
IDSA Clinical Practice ... Rhinosinusitis Algorithm ... - Overall Treatment ... NNH = 8 (mostly GI ... Management #IDSA #2012
Functional GI Disorders in IBD - IBD Algorithm

Background:
 • 25-40% of IBD in remission have IBS
Functional GI Disorders ... in IBD - IBD Algorithm ... Disorders #IBS #IBDAlgorithm ... #IBD #Algorithm ... gastroenterology #management #treatment
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Vasculitis Management Algorithm ... - ACR/VF 2021 Guidelines ... Symptoms/Loss or Critical ... Vasculitis #Management #Treatment ... ACR2021 #Guidelines #algorithm
Mild-to-Moderate Ulcerative Colitis - Management Algorithm
Curcumin:
 • Natural phytochemical from turmeric
 • 2g/day divided in 2-3
Colitis - Management Algorithm ... placebo • Potential GI ... Nissle • VSL#3: ↑ clinical ... 5-ASA brands Algorithm ... #treatment #IBD
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 ... Dosing: 250 mcg tablet ... daily The 2019 ... recommendations for the treatment ... won’t have any clinical
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
event, follow ACC algorithm ... Change in clinical ... PCI/DES ( Levine 2016 ... since ACS ( Levine 2016 ... stroke ( Doherty 2017